The Claim

In older adults aged 65–85, once-weekly 6 mg sirolimus combined with a moderate home exercise program over 13 weeks is safe and tolerable, with adverse events monitored via clinical labs, vital signs, and participant reporting, although the small sample size limits the ability to detect rare side effects.

Source: A single-center, double-blind, randomized, placebo-controlled, two-arm study to evaluate the safety and efficacy of once-weekly sirolimus (rapamycin) on muscle strength and endurance in older adults following a 13-week exercise program

What the research says

Not yet evaluated

We are still looking at what the research says.

Supports
0score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
0 studies reviewed
In plain English

Taking a weekly 6 mg dose of sirolimus seems to be safe for older adults (65–85 years old) if they also do light home exercises for 13 weeks — most side effects were caught through check-ups and self-reports, but the study was too small to catch very rare ones.

See the scientific wording

Once-weekly 6 mg sirolimus appears to be safe and tolerable in older adults aged 65–85 when combined with a moderate home exercise program over 13 weeks, with adverse events monitored through clinical labs, vital signs, and participant reporting, though the small sample limits detection of rare side effects.

Score breakdown, mechanism chain, raw evidence, ideal studies needed

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.